title: Metastatic placental site trophoblastic tumor.
abstract: A patient with metastatic placental site trophoblastic tumor is presented. Her treatment included several aggressive chemotherapeutic regimens. In this patient, the clinical course and assays of beta-hCG (beta fragment of human chorionic gonadotropin) correlated with her response to these treatments.
authors.affiliation: Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, DC 20307.
authors.forename: R
authors.initials: R
authors.lastname: Alvero
authors.forename: S
authors.initials: S
authors.lastname: Remmenga
authors.forename: D
authors.initials: D
authors.lastname: O'Connor
authors.forename: D
authors.initials: D
authors.lastname: Barnhill
authors.forename: R
authors.initials: R
authors.lastname: Park
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D010922:Placenta Diseases / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D011247:Pregnancy; D013534:Survival; D014057:Tomography, X-Ray Computed; D014328:Trophoblastic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*
chemical_list: D006063:Chorionic Gonadotropin; D003609:Dactinomycin; D003520:Cyclophosphamide; D008727:Methotrexate